Sci Pharmtech
Sci Pharmtech, officially known as Sci Pharmtech Co., Ltd., is a leading player in the pharmaceutical technology industry, headquartered in Taiwan (TW). Founded in 2005, the company has established a strong presence in major operational regions across Asia and beyond, focusing on innovative solutions for drug formulation and delivery systems. Specialising in advanced pharmaceutical technologies, Sci Pharmtech offers a range of unique products and services, including customised drug delivery systems and formulation development. Their commitment to quality and innovation has positioned them as a trusted partner for pharmaceutical companies seeking to enhance their product offerings. With a reputation for excellence, Sci Pharmtech has achieved significant milestones, including collaborations with renowned global pharmaceutical firms. Their dedication to research and development continues to drive their market position, making them a key contributor to advancements in the pharmaceutical sector.
DitchCarbon Score
How does Sci Pharmtech's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sci Pharmtech's score of 2 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sci Pharmtech's reported carbon emissions
In 2023, Sci Pharmtech reported total carbon emissions of approximately 10,570,000 kg CO2e, comprising 2,416,000 kg CO2e from Scope 1 and 8,154,000 kg CO2e from Scope 2. This represents a significant increase in emissions compared to previous years, with 2022 emissions recorded at about 6,289,000 kg CO2e. The company has shown a trend of fluctuating emissions over the years, with 2020 emissions at 16,282,000 kg CO2e, which included 97,000 kg CO2e from Scope 1 and 10,047,000 kg CO2e from Scope 2. In 2021, emissions decreased to approximately 1,644,000 kg CO2e, indicating a positive reduction effort during that period. Despite these figures, Sci Pharmtech has not disclosed any specific reduction targets or initiatives, nor have they committed to the Science Based Targets initiative (SBTi). Their emissions intensity per unit of revenue has varied, with a notable decrease from 0.18 in 2017 to 0.14 in 2018, reflecting an improvement in operational efficiency. Overall, while Sci Pharmtech has made strides in managing emissions intensity, the lack of formal reduction targets or climate pledges suggests an opportunity for further commitment to climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 97,000 | 00,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 10,047,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sci Pharmtech is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
